Literature DB >> 31740139

Characteristics and in-hospital mortality of patients with myocardial infarction in the absence of obstructive coronary artery disease in super-aging society.

Masanobu Ishii1, Koichi Kaikita2, Kenji Sakamoto3, Tomotsugu Seki4, Koji Kawakami4, Michikazu Nakai5, Yoko Sumita5, Kunihiro Nishimura5, Yoshihiro Miyamoto5, Teruo Noguchi5, Satoshi Yasuda5, Hiroyuki Tsutsui6, Issei Komuro7, Yoshihiko Saito8, Hisao Ogawa8, Kenichi Tsujita3.   

Abstract

BACKGROUND: Myocardial infarction with nonobstructive coronary arteries (MINOCA) is a common presentation of acute myocardial infarction (AMI) and has a better prognosis. However, there were few reports on large-scale, high aged population. The aim of this study was to determine the differences in the clinical characteristics and short-term prognosis between MINOCA and myocardial infarction with obstructive coronary artery disease (MI-CAD) using a nationwide administrative database in the super-aging society, Japan.
METHODS: This was an observational study using data of 137,678 AMI patients who underwent angiography between April 2012 through March 2016. Using the international classification of diseases 10th revision, AMI patients were divided into two groups based on the presence or absence of revascularization and coronary atherosclerosis, identifying 123,633 MI-CAD and 14,045 working diagnosis of MINOCA patients. The true MINOCA (n = 13,022) was defined as the MINOCA excluding non-ischemic causes. We assessed in-hospital mortality within 30 days.
RESULTS: Both MINOCA groups were typically found in non-obese, non-smoker young females, with a low grade on Killip classification, and non-low ADL status. Compared to MI-CAD, chronic pulmonary diseases, peripheral vascular diseases, liver diseases, renal diseases, and cerebrovascular diseases were more common, whereas diabetes was less common in the MINOCA groups. In-hospital mortality within 30 days was higher in both MINOCA groups than in MI-CAD. Multivariate frailty model identified both MINOCA groups as an independent risk factor for in-hospital mortality.
CONCLUSIONS: Our large-population study demonstrated that MINOCA was associated with a high risk of in-hospital mortality compared with MI-CAD in the super-aging society.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31740139     DOI: 10.1016/j.ijcard.2019.09.037

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  Influence of neutrophil-to-lymphocyte ratio and mean platelet volume on severity and short-term prognosis of acute ischemic stroke.

Authors:  Weimin Xue; Yaqiang Li; Henglei Xia; Tingting Yu; Shiyu Sun; Mei Zhang
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Resources for cardiovascular healthcare associated with 30-day mortality in acute myocardial infarction with cardiogenic shock.

Authors:  Masanobu Ishii; Kenichi Tsujita; Hiroshi Okamoto; Satoshi Koto; Takeshi Nishi; Michikazu Nakai; Yoko Sumita; Yoshitaka Iwanaga; Nobuyoshi Azuma; Satoaki Matoba; Ken-Ichi Hirata; Yutaka Hikichi; Hiroyoshi Yokoi; Yuji Ikari; Shiro Uemura
Journal:  Eur Heart J Open       Date:  2021-12-31

Review 3.  Myocardial Infarction With Non-obstructive Coronary Arteries: An Updated Overview of Pathophysiology, Diagnosis, and Management.

Authors:  Arshan Khan; Abdelilah Lahmar; Maria Riasat; Moiz Ehtesham; Haris Asif; Warisha Khan; Muhammad Haseeb; Hetal Boricha
Journal:  Cureus       Date:  2022-03-29

4.  Case Report: Pulmonary Vein Isolation as a Tailored Treatment for Recurrent Ventricular Tachycardia During Hemodialysis in a Patient With Right Coronary Artery Chronic Total Occlusion.

Authors:  Cosmin Cojocaru; Adelina Pupăză; Corneliu Iorgulescu; Sebastian Onciul; Lucian Câlmâc; Radu Vătăşescu
Journal:  Front Cardiovasc Med       Date:  2022-05-30

5.  MINOCA: The caveat of absence of coronary obstruction in myocardial infarction.

Authors:  Nousjka P A Vranken; Tobias F S Pustjens; Evelien Kolkman; Renicus S Hermanides; Sebastiaan C A M Bekkers; Martijn W Smulders; Yvonne J M van Cauteren; Jordi Heijman; Saman Rasoul; Jan P Ottervanger; Arnoud W J van 't Hof
Journal:  Int J Cardiol Heart Vasc       Date:  2020-07-01

6.  Associations of cardiovascular risk factors with survival outcomes in a cancer registration: Findings from the KUMAMON registry.

Authors:  Yuji Maki; Daisuke Sueta; Masanobu Ishii; Yoshinori Yamanouchi; Koichiro Fujisue; Kenshi Yamanaga; Taishi Nakamura; Noriaki Tabata; Yuichiro Arima; Satoshi Araki; Eiichiro Yamamoto; Koichi Kaikita; Akira Chikamoto; Kenichi Matsushita; Masao Matsuoka; Koichiro Usuku; Kenichi Tsujita
Journal:  Medicine (Baltimore)       Date:  2021-11-24       Impact factor: 1.817

7.  Wnt 3a Protects Myocardial Injury in Elderly Acute Myocardial Infarction by Inhibiting Serum Cystatin C/ROS-Induced Mitochondrial Damage.

Authors:  Jian Shen; Ying Li; Yang Jiao; Jihang Wang; Xiaoling Hou; Yongkang Su; Bing Liu; Henan Liu; Zhijun Sun; Qing Xi; Zhenhong Fu
Journal:  Front Physiol       Date:  2022-07-22       Impact factor: 4.755

Review 8.  Research progress in endothelial cell injury and repair.

Authors:  Yongpan Huang; Chong Song; Jianbin He; Min Li
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

9.  Clinical presentation and 3-year outcomes of patients with acute coronary syndromes and non-obstructive coronary arteries on angiography.

Authors:  Lukasz Zandecki; Agnieszka Janion-Sadowska; Jacek Kurzawski; Lukasz Piatek; Michal Zabojszcz; Krzysztof Plens; Zbigniew Siudak; Marcin Sadowski
Journal:  PLoS One       Date:  2020-06-16       Impact factor: 3.240

10.  Can Aspirin Use Be Associated With the Risk or Prognosis of Bladder Cancer? A Case-Control Study and Meta-analytic Assessment.

Authors:  Bo Fan; Alradhi Mohammed; Yuanbin Huang; Hong Luo; Hongxian Zhang; Shenghua Tao; Weijiao Xu; Qian Liu; Tao He; Huidan Jin; Mengfan Sun; Man Sun; Zhifei Yun; Rui Zhao; Guoyu Wu; Xiancheng Li
Journal:  Front Oncol       Date:  2021-07-19       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.